We would like to thank the author for the interest shown in our article.
We were able to access the article mentioned but as no abstract was
available, neither was there a link to the full text of the article;
hence, the inadvertent error.
The aim of writing this article was to acknowledge the
emerging role of sildenafil in neonatology and to encourage colleagues to
report use of the drug for all to benefit. We share the authors concern on
the lack of an effective system of drug regulation and monitoring. The
burden of regulation and off label use of drugs rests with the state and
the laws of the land, as much as with the conscience of the practising
physician. However we agree that there should be some regulation to check
and ensure safety of newborn care, our article clearly discourages the use
of sildenafil by the individual practitioner other than in a research
setting.